Genetic characteristics of 2009 pandemic H1N1 influenza a viruses isolated from Mainland China

Virologica Sinica

Volumn 26, Issue 6, 2011, Pages 418-427

  Zhao, Jiu Ru ^a   Li, Yong Dong ^b   Pan, Li Min ^a   Zhu, Na ^a   Ni, Hong Xia ^b   Xu, Guo Zhang ^b   Jiang, Yong Zhong ^b   Huo, Xi Xiang ^b   Xu, Jun Qiang ^b   Xia, Han ^a   Han, Na ^a   Tang, Shuang ^a   Zhang, Zhong ^a   Kou, Zheng ^a   Rayner, Simon ^a   Li, Tian Xian ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

H1N1; Key sites; Mutations; Phylogenetic analysis

Indexed keywords

ADAMANTANE; AMINO ACID;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING SITE; CELL STRAIN; CHINA; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; HUMAN; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; SEQUENCE HOMOLOGY; THROAT CULTURE; UNINDEXED SEQUENCE; VIRAL GENETICS; VIRUS GENOME; VIRUS ISOLATION; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TRANSMISSION;

AMINO ACID SEQUENCE; CHINA; GENETIC VARIATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MOLECULAR SEQUENCE DATA; PANDEMICS; PHYLOGENY; SEQUENCE ALIGNMENT; VIRAL PROTEINS;

INFLUENZA A VIRUS;

EID: 84855228758     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-011-3228-3     Document Type: Article

References (16)

1. Robert. Belshe 2009 Implications of the emergence of a novel H1 influenza virus N Engl J Med. 360 2667 2668 19423870 10.1056/NEJMe0903995 1:CAS:528:DC%2BD1MXntlKmtLo%3D
2. K. Bragstad L. P. Nielsen A. Fomsgaard 2008 evolution of human influenza A viruses from 1999 to 2006: A complete genome study Virol J 5 40 1 19
3. CDC. 2009. Realtime RTPCR (rRTPCR) Protocol for Detection and Characterization of Swine Influenza (version2009). http://www.who.int/csr/ restheces/publications/swineflu/realtimeptpcr/en/index.html.
4. J. Cinatl Jr M. Michaelis H. W. Doerr 2007 The threat of avian influenza A (H5N1) Part I: Epidemiologic concerns and virulence determinants. Med Microbiol Immunol 196 181 190
5. V. M. Deyde T. G. Sheu A. A. Trujillo 2010 Detection of Molecular Markers of Drug Resistance in 2009 Pandemic Influenza A (H1N1) Viruses by Pyrosequencing Antimicrob Agents Ch 54 3 1102 1110 10.1128/AAC.01417-09 1:CAS:528:DC%2BC3cXjtFWqs7k%3D
6. E. J. Dunham V. G. Dugan E. K. Kaser 2009 Different Evolutionary Trajectories of European Avian-Like and Classical Swine H1N1 Influenza A Viruses J Virol 83 11 5485 5494 19297491 10.1128/JVI.02565-08 1:CAS:528: DC%2BD1MXmtlGlu7c%3D
7. European Centre for Disease Prevention and Control special report. The 2009 A(H1N1) pandemic in Europe. http://www.ecdc.europa.eu/en/publications/ Publications/101108-SPR-pandemic-experience.pdf.
8. Galwankar S, Clem A. 2009. Swine influenza A (H1N1) strikes a potential for global disaster. J Emerg Trauma Shock, 99-105.
9. J. A. Mould J. E. Drury S. M. Frings 2000 Permeation and activation of the M2 ion channel of influenza A virus J Biol Chem 275 31038 31050 10913133 10.1074/jbc.M003663200 1:CAS:528:DC%2BD3cXntlCisrg%3D
10. Nelson M, Spiro D, Wentworth D, et al. 2009. The early diversification of influenza A/H1N1pdm. PLoS Curr, RRN1126.
11. S. Puzelli M. Facchini A. Di Martino 2011 Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic Antiviral Res. 90 205 212 21514326 10.1016/j.antiviral.2011.04.003 1:CAS:528:DC%2BC3MXmvFSktro%3D
12. V. Shinde C. B. Bridges T. M. Uyeki 2009 Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009 N Engl J Med. 360 2616 2625 19423871 10.1056/NEJMoa0903812 1:CAS:528:DC%2BD1MXntlKiurg%3D
13. E. K. Subbarao W. London B. R. Murphy 1993 A single amino acid in the PB2 gene of influenza A virus is a determinant of host range J Virol 67 1761 1764 8445709 1:CAS:528:DyaK3sXitVKltbk%3D (Pubitemid 23088345)
14. Wetherall N T, Trivedi T, Zeller J, et al. 2003. Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol, 742-750. (Pubitemid 36184190)
15. World Health Organization 2010 Update on oseltamivir-resistant pandemic A (H1N1) 2009 influenza virus Wkly Epidemiol 85 37 48
16. J. R. Yang Y. C. Lin Y. P. Huang 2011 Reassortment and Mutations Associated with Emergence and Spread of Oseltamivir-Resistant Seasonal Influenza A/H1N1 Viruses in 2005-2009 PLoS ONE. 6 3 e18177 21483816 10.1371/journal.pone. 0018177 1:CAS:528:DC%2BC3MXkvVeqsLc%3D